Skip to main content

Advertisement

Table 3 Quality of life

From: One-year resource utilisation, costs and quality of life in patients with acute respiratory distress syndrome (ARDS): secondary analysis of a randomised controlled trial

  6 months 12 months Quality-adjusted survival at 12 months
  Mean EQ5D index (95 % CI) Mean EQ5D index (95 % CI) Mean QALY (95 % CI)
All patients 0.5622 (0.5163–0.6081) 0.5831 (0.5348–0.6314) 0.2676 (0.2457–0.2894)
Age    
 <65 0.55 (0.49–0.60) 0.58 (0.53-0.64) 0.31 (0.28-0.35)
 ≥65 0.62 (0.52–0.71) 0.58 (0.48–0.68) 0.16 (0.12–0.21)
Gender    
 Male 0.57 (0.51–0.63) 0.58 (0.52–0.64) 0.27 (0.23–0.30)
 Female 0.55 (0.47–0.63) 0.59 (0.51–0.67) 0.27 (0.23–0.31)
APACHE II    
 <26 0.57 (0.52–0.62) 0.57 (0.52–0.63) 0.29 (0.26–0.33)
 ≥26 0.48 (0.34–0.61) 0.60 (0.50–0.71) 0.16 (0.12–0.20)
PaO2:FiO2 ratio (KPa)    
 <15 0.57 (0.51–0.64) 0.58 (0.51–0.65) 0.23 (0.20–0.27)
 ≥15 0.55 (0.48–0.63) 0.59 (0.52–0.65) 0.31 (0.27–0.35)
Ventilation method    
 Conventional 0.52 (0.45–0.59) 0.55 (0.48–0.61) 0.25 (0.21–0.29)
 HFOV 0.61 (0.54–0.67) 0.62 (0.55–0.69) 0.29 (0.25–0.33)